Join
Live feed
·
INSIDERFilingvia Quantisnow
Athira Pharma Inc. logo

CFO and Chief Business Officer Gengos Andrew was granted 15,000 shares and sold $720 worth of shares (1,272 units at $0.57), increasing direct ownership by 16% to 97,532 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATHA (Athira Pharma Inc.) and more on Quantisnow.